www.cancerindetail.com

Dedicated runner thought he was in perfect health

14 hrs ago | stltoday.com

Home • St. Charles. Occupation • Area director of operations for Spectrum Retirement of Missouri. What he did • While battling colon and rectal cancer, he has continued distance running, but now he does it to fight the disease.... Read more...

Harry Jackson Jr Heigl tumor Siteman chemo runner cancer colon resection meter liver www.stlouisseniorolympics.org health fatigue rectal doctor gorilla Spectrum sometimes

Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver...

10 hrs ago | checkorphan.org

Cellular Biomedicine Group announced that it has achieved half of the enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of TC-DC (Tumor Stem Cell... Read more...

TC-DC cell enrollment therapy Biomedicine cellular trial clinical HCC liver tumor patient CBMG phase immune recurrence

Jennerex Completes $21.6 Million Private Placement

8 hrs ago | firmenpresse.de

SAN FRANCISCO, CA -- (Marketwired) -- 05/23/13 -- Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic... Read more...

Pexa-Vec Jennerex tumor $21.6 cancer oncolytic Phase TRAVERSE

Adding Cetuximab to Chemotherapy Increases Resection Rates of Colorectal Liver Metastases and...

6 hrs ago | onclive.com

The addition of cetuximab to chemotherapy as first-line treatment of KRAS wild-type unresectable colorectal liver metastases resulted in a higher rate of resection and longer survival than chemotherapy alone Read more...

resection cetuximab liver metastasis patient chemotherapy CLM CLMs chemotherapy-alone tumor study adding PFS chemotherapy-only OS

image

Jennerex Completes $21.6 Million Private Placement

8 hrs ago | newsblaze.com

Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that it has... Read more...

Jennerex $21.6 placement tumor Pexa-Vec private oncolytic complete immunotherapy

Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc

14 hrs ago | sectorpublishingintelligence.co.uk

World News: 07:00 GMT Thursday 23rd May 2013. [Nordion Inc. via Businesswire] Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced... Read more...

Nordion BTG TheraSphere Therapies Targeted transaction plc www.nordion.com

BTG builds interventional medicine platform with deals

6 hrs ago | expatnewsletter.net

LONDON | Thu May 23, 2013 8:01am BST LONDON (Reuters) – Britain’s BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an... Read more...

Expatnewsletter.Net BTG interventional medicine Nordion bead deal Therasphere EkoSonic clot Varisolve

GBK & Sparkling Hill Resort Hosted a Luxury Lounge in Honor of the 2013 Cannes Film Festival at...

1 hr ago | prweb.com

GBK & Sparkling Hill Resort gifted Top Celebrities throughout the Cannes Film Festival. Sparkling Hill Wellness Hotel A true highlight of the lounge was Sparkling Hill Resort, a European-inspired wellness resort known as the... Read more...

GBK GBK&Sparkling Cannes resort Hill lounge gift festival luxury Sparkling Swarovski

image

ReformedBroker: Land of the Lost http://t.co/wANWVXPzK8

May 22, 2013 | redliontrader.com

Post navigation ← felixsalmon: A timely reminder that it’s not just Apple: they all do it. http://t.co/3JQYNIMiAu There’s A Huge Flaw In Yahoo’s Monetization Plan For Tumblr (YHOO) → PALO ALTO, Calif., May 22, 2013 /PRNewswire/... Read more...

Twitterfeed Enzoani CBMG TC-DC GEDC patient cell t.co Behrmann therapy Biomedicine Yenter

NASDAQ:DCTH Investor Alert: Lawsuit against Delcath Systems, Inc. filed

May 22, 2013 | empowerednews.net

The Shareholders Foundation announces that an investor in shares of Delcath Systems, Inc. (NASDAQ:DCTH) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal... Read more...

Trevor Allen Delcath NASDAQ:DCTH Systems Inc. Melblez 2013

Science: Researchers from Peking University Cancer Hospital and Institute Describe Findings in...

May 22, 2013 | newsrx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on Science. According to news reporting originating from Beijing, People's Republic of China, by NewsRx correspondents, research... Read more...

1B50-1 a2d1 Beijing TICs institute cancer science HCC researcher finding university www.elsevier.com hospital Proteins describe Calcium

Celsion Announces Issuance Of Additional Patents Covering ThermoDox® Technologies

May 22, 2013 | dailymarkets.com

Patents Extend ThermoDox® IP to 2026 in Largest Markets for Hepatocellular Carcinoma LAWRENCEVILLE, N.J., May 22, 2013 /PRNewswire/ – Celsion Corporation (NASDAQ:CLSN) announced today that its proprietary patent application,... Read more...

Celsion ThermoDox patent HEAT liposomal technology

Natural Sciences Repository Publishes New Information on Liver Disease and on Disease Resistance

May 22, 2013 | prweb.com

The novel Natural Sciences Repository aims to provide reliable information on various areas of scientific interest in the simplest words and terms possible. The site has now added new scientific information on liver disease... Read more...

disease liver resistance category organism repository contain scientific

image

The ART of decision making: Retreatment with transarterial chemoembolization in patients with...

May 22, 2013 | wiley.com

Article first published online: 3 MAY 2013 Hepatology Early View (Online Version of Record published before inclusion in an issue) How to Cite Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl,... Read more...

Wolfgang Sieghart TACE ART transarterial chemoembolization retreatment Peck-Radosavljevic Hepatology Pharma Schering Heinzl Trauner Sieghart M. cohort patient grant Vienna ≥2.5

image

4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in...

May 21, 2013 | pressebox.de

Planegg-Martinsried, Germany, 21.05.2013 - . - Phase I/II study to investigate safety and efficacy of resminostat/sorafeni­b combination vs. sorafenib alone as first-line treatment of advanced liver cancer... Read more...

resminostat 4SC Yakult Honsha sorafenib HCC Phase cancer clinical II

Treating Cancer - Cannabis and Cannabinoids

May 20, 2013 | newsvine.com

This information may be useful for people that have cancer or for people that have a loved one with cancer. Cannabinoids are useful in treating the side effects of cancer and for cancer treatment. Cannabinoids are active... Read more...

National Cancer Institute Cannabinoids cancer cell delta-9-THC cannabinoid receptor cannabidiol effect

Death By Toothpaste Part II: All Natural Alternatives to Toxic Toothpaste Ingredients

May 20, 2013 | liveinthenow.com

As the father of two young kids, I do all that I can to reduce their exposure to toxins and chemicals. One of these efforts includes having them use natural toothpaste , as I discussed in Part I of this two-part series .... Read more...

Joshua Corn toothpaste tooth ingredient natural toxic triclosan fluoride

image

HIV no barrier to getting liver transplant: study

May 21, 2013 | thenews.com.pk

Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research. The Italian study, published May 10 in the journal The Oncologist, found that the... Read more...

liver HIV transplant HCC patient study barrier HIV-positive getting

Medical Publication Reveals that Cardio May Cure Liver Cancer, Making Energy Enhancing...

May 21, 2013 | prweb.com

New research suggests that being physically active may cure liver cancer, meaning that energy enhancing weight loss supplements like Prescopodene by Prescopodene Nutritionals may assist in overall health and wellness. Australia... Read more...

Prescopodene Liver Nutritionals Cancer mouse weight supplement tumor sedentary May active all-natural

re: First-Ever Lifetime Feeding Study Finds Genetically Engineered Corn Causes Massive Tumors,...

May 21, 2013 | mercola.com

Visit the Mercola Video Library By Dr. Mercola The first-ever lifetime feeding study 1 evaluating the health risks of genetically engineered foods was published online on September 19, and the results are troubling, to say the... Read more...

GE genetically glyphosate corn study Monsanto food YieldGard engineered crop plant Bt Roundup-Ready gene Feeding Roundup tumor

DDW 2013 - Experts review NAFLD treatment options

May 21, 2013 | hepatitiscnewdrugs.blogspot.cz

Experts review NAFLD treatment options Non-alcoholic fatty liver disease (NAFLD) is a common condition that, without signs of fibrosis, may be benign. But with fibrosis, NAFLD can progress to non-alcoholic steatohepatitis... Read more...

NAFLD NASH DDW patient Vuppalanchi Kowdley fibrosis Dr. hepatology

A cup of coffee a day can prevent liver disease

May 21, 2013 | merinews.com

A cup of coffee a day has been found to be a protection against a rare disease that can lead to liver failure and cancer. This has also been found to be good for heavy drinkers of alcohol, as coffee reduces their risk of liver... Read more...
All similar articles: 125 »

liver coffee disease cup GGT PSC prevent Cafestol Gamma-glutamyl

Baby Boomers Urged to Get Tested for Hepatitis C Virus

May 21, 2013 | finanznachrichten.de

KANSAS CITY, Mo., May 21, 2013 /PRNewswire-USNewswire/ -- If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor... Read more...

hepatitis C boomer liver test virus baby Saint follow-up Luke

Students bring classmate silly socks at ACH

May 21, 2013 | todaysthv.com

A second grader battling liver cancer received a special delivery Monday. Students bring classmate, Chance Storz, silly socks at Arkansas Children's Hospital WHITE HALL, Ark. (KTHV) -- A second grader battling liver cancer... Read more...

sock Storz silly classmate student Chance grader battling liver

image

Lung Cancer, Not One Disease: Diverse Patients Need Personalized Treatments, Two New Studies Show

May 20, 2013 | drugs.com

Canada NewsWire BURLINGTON, ON, May 16, 2013 Data Presented at American Society of Clinical Oncology (ASCO) on two Boehringer Ingelheim Phase III Oncology Compounds, Afatinib* and Nintedanib*, Show Progression Free Survival in... Read more...

lung EGFR cancer afatinib nintedanib Ingelheim Boehringer patient NSCLC LUX-Lung LUME-Lung Ibid. treatment pemetrexed receptor chemotherapy first-line Oncology

BTG PLC : Final Results

May 20, 2013 | investegate.co.uk

Strong financial performance enabling continued investment in growth strategy London, UK, 20 May 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2013. ━... Read more...

BTG Licensing&Biotechnology US royalty product Beads PEM AZD9773 Voraxaze patient ━ Bead™ DigiFab 12 11 prior approval Varisolve Zytiga operating Bead revenue

image

MultiCell Technologies Files U.S. Patent Application For Targeted Delivery Of Noncoding Micro...

May 20, 2013 | bioresearchonline.com

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a noncoding double... Read more...

MultiCell MCT-485 tumor patent micro cell targeted carcinoma miRNAs

Nano-vehicles for Cancer Drugs

May 20, 2013 | the-scientist.com

Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy. By James Netterwald | May 20, 2013 Great things sometimes come in small... Read more...
All similar articles: 579 »

James Netterwald drug cancer tumor nanoparticles docetaxel liposome BIND-014 nanoparticle liver PLA liposomes BIND nanomedicine

Bayer Initiates Phase III Trial of Stivarga (regorafenib) Tablets in Patients with Advanced Liver...

May 20, 2013 | drugs.com

WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III... Read more...

Stivarga regorafenib Bayer HCC RESORCE Patients tumor Hepatocellular Phase patient unresectable III

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Delcath Systems, Inc.

May 20, 2013 | fortmilltimes.com

Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of a class (the “Class”) comprising all purchasers of the... Read more...

Delcath Binkow&Goldberg Glancy LLP Melblez class 682-5340 lawsuit 773-9224 Period